The Boston-type craniosynostosis mutation MSX2 (P148H) results in enhanced susceptibility of MSX2 to ubiquitin-dependent degradation.
about
The canonical BMP signaling pathway plays a crucial part in stimulation of dentin sialophosphoprotein expression by BMP-2MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling.FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization.Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation.Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva.Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient miceMolecular regulation of matrix extracellular phosphoglycoprotein expression by bone morphogenetic protein-2Protein microarrays for the identification of praja1 e3 ubiquitin ligase substrates.Craniosynostosis and Resynostosis: Models, Imaging, and Dental Implications.PIAS1 negatively regulates ubiquitination of Msx1 homeoprotein independent of its SUMO ligase activityWnt3a stimulates Mepe, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression.Large parietal midline defect with unusual ridge-like structure at the rim and persistent falcine sinus.Second family with the Boston-type craniosynostosis syndrome: novel mutation and expansion of the clinical spectrum.PJA1 Coordinates with the SMC5/6 Complex to Restrict DNA Viruses and Episomal Genes through Interferon-independent Manner
P2860
Q24299791-6523E704-36D8-4389-8634-EF76A195AACAQ33361639-C900F9C9-86FE-4742-BABB-8ABC8369E969Q33661959-3A37BC02-9615-4E34-8001-700A65D66161Q33942820-1F410C4C-09B0-42CE-A35A-51DD8E0EA28EQ33991272-378057F6-C793-41B8-9858-5ADD4665A6C9Q36635990-A1C040A1-D9D6-4DDB-9AE3-C98155EB7092Q37375766-E8053A5E-1347-4A5C-B5EF-22CF7D90B091Q38502781-517C8C9D-0AB1-4492-8DA1-B62E28684F45Q38807892-FE0A8D0B-E44C-4E05-8D8F-EBA06972927EQ41864194-564FCD17-A9BA-4EB5-B32B-1B33E2227FAFQ42801437-D75B2645-B4B2-4DC0-9E2E-6B7907B6C663Q45401350-D5BAA615-A36E-4F80-9740-0F98E7B2662DQ53099238-C2BC0C09-371B-4394-9F86-F755F7E2374EQ58706102-1EEA1976-E115-478D-B0A0-00EAFDE79633
P2860
The Boston-type craniosynostosis mutation MSX2 (P148H) results in enhanced susceptibility of MSX2 to ubiquitin-dependent degradation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The Boston-type craniosynostos ...... iquitin-dependent degradation.
@en
The Boston-type craniosynostosis mutation MSX2
@nl
type
label
The Boston-type craniosynostos ...... iquitin-dependent degradation.
@en
The Boston-type craniosynostosis mutation MSX2
@nl
prefLabel
The Boston-type craniosynostos ...... iquitin-dependent degradation.
@en
The Boston-type craniosynostosis mutation MSX2
@nl
P2093
P2860
P356
P1476
The Boston-type craniosynostos ...... iquitin-dependent degradation.
@en
P2093
Gwan-Shik Kim
Hyun-Mo Ryoo
Je-Yoel Cho
Jeong-Hwa Baek
Kwang-Hwi Cho
Kyung-Mi Woo
Won-Joon Yoon
Young-Dan Cho
P2860
P304
32751-32761
P356
10.1074/JBC.M803183200
P407
P577
2008-09-10T00:00:00Z